Number of patients with observed PK concentration data used in the analysis by study, cancer type and dosing regimen

StudyCancer Type2 mg/kg Q3W10 mg/kg Q3W10 mg/kg Q2W200 mg Q3W
KEYNOTE-001Melanoma165309176
KEYNOTE-001NSCLC61288204
KEYNOTE-002Melanoma207212
KEYNOTE-006Melanoma270272
KEYNOTE-010NSCLC327326
KEYNOTE-024NSCLC152
KEYNOTE-045Urothelial Cancer262
KEYNOTE-052Urothelial Cancer311
KEYNOTE-055HNSCC47
KEYNOTE-164MSI-H58

There are patients with missing indication for N = 24 from KEYNOTE-001, 002 and 006

NSCLC Non–Small Cell Lung Cancer, HNSCC Head and Neck Squamous Cell Carcinoma, MSI-H Microsatellite Instability-High Carcinoma